Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial of Fruquintinib in patients with advanced non-small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: A Two-arm (Phase 2) Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China [Phase 2]
A Phase 2 two-arm exploratory trial evaluating nivolumab alone or combined with nab-paclitaxel and carboplatin in early-stage non-small cell…
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Pemetrexed vs Pemetrexed Plus Cisplatin in EGFR-mutant NSCLC Patients After First Line EGFR-TKIs Failure [Phase 2]
Phase 2 trial comparing pemetrexed alone versus pemetrexed plus cisplatin in EGFR-mutant non-small cell lung cancer after failure of first-l…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: A Study of the Efficacy and Safety of Alectinib in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of alectinib in ALK-rearranged non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil [NA]
A completed clinical trial investigating minocycline and armodafinil to reduce symptom burden from chemoradiation in non-small cell lung can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Rh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLC [Phase 2]
Phase 2 trial examining rh-endostatin in combination with chemotherapy and pembrolizumab for advanced stage IV non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid Tumors [Phase 1]
Phase 1 trial evaluating PEGPH20 with pembrolizumab in hyaluronan-high tumors including non-small cell lung cancer and gastric cancer; study…
-
CLINICAL_TRIALS trial_result · 2020-02-06Clinical Trial Update: Third-line Treatment of Gefitinib in NSCLC Patients [Phase 2]
A Phase 2 clinical trial update evaluating third-line gefitinib in non-small cell lung cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05) [Phase 2]
Phase 2 trial KEYNOTE-654-05/ECHO-305-05 comparing pembrolizumab plus epacadostat versus pembrolizumab plus placebo in metastatic non-small …
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLC [Phase 2]
Phase 2 trial of SHR-1210 (an anti-PD-1) combined with hypofractionated radiotherapy in non-small cell lung cancer (NSCLC).
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 clinical trial evaluating durvalumab with chemotherapy and SBRT for oligometastatic non-small cell lung cancer. The status is curren…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Sintilimab Versus Pembrolizumab for Advanced-stage Non-Small-Cell Lung Cancer [Phase 2]
Phase 2 trial comparing sintilimab to pembrolizumab for advanced non-small cell lung cancer is ongoing with unpublished status.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study of Viagenpumatucel-L (HS-110) in non-small cell lung cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: A Study of NIVO Plus IPI and Guadecitabine or NIVO Plus IPI in Melanoma and NSCLC Resistant to Anti-PD1/PDL1 [Phase 2]
Phase 2 trial evaluating nivolumab plus ipilimumab with guadecitabine versus nivolumab plus ipilimumab in melanoma and non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC [Phase 2]
Phase 2 clinical trial update evaluating SBRT for inoperable centrally located non-small cell lung cancer (Stage I-II).
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06) [Phase 2]
Phase 2 trial evaluating pembrolizumab plus epacadostat with platinum-based chemotherapy versus pembrolizumab with platinum chemotherapy plu…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: A Study of SH-1028 Tablets Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial comparing SH-1028 tablets to gefitinib in locally advanced or metastatic non-small cell lung cancer is in progress,…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer [Phase 2]
Phase 2 clinical trial evaluating PD-1 monoclonal antibody SHR-1210 in combination with apatinib for advanced non-small cell lung cancer, so…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Anticancer Activity of Nicotinamide on Lung Cancer [Phase 2, Phase 3]
A clinical trial update reports anticancer activity of nicotinamide in non-small cell lung carcinoma across Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer [Phase 1, Phase 2]
Phase 1/2 trial update for an experimental in-situ cancer vaccine across multiple solid tumors, including breast, colorectal, prostate, mela…
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating PET-adjusted intensity-modulated radiation therapy with combination chemotherapy in stage II-IV non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update for the BATTLE program evaluating Tarceva and Targretin in patients with advanced non-small cell lung cancer (NSCLC).
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer [Phase 1]
Phase 1 feasibility trial evaluating navigational bronchoscopy-guided photodynamic therapy with Photofrin in unresectable peripheral lung ca…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: OMEGA, Local Ablative Therapy in Oligometastatic NSCLC [Phase 3]
Phase 3 trial evaluating local ablative therapy (OMEGA) in oligometastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: GIOTRIF in First Line Therapy of Advanced NSCLC With EGFR-mutations
Clinical trial update for GIOTRIF in first-line therapy of advanced non-small cell lung cancer with EGFR mutations; study completed with res…